The vascular protective properties of kinsenoside isolated from Anoectochilus roxburghii under high glucose condition.

[1]  Y. Shoyama,et al.  Pharmacologically active compounds in the Anoectochilus and Goodyera species , 2008, Journal of Natural Medicines.

[2]  J. Raffetto,et al.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. , 2008, Biochemical pharmacology.

[3]  Yonghui Zhang,et al.  Antihyperglycemic activity of kinsenoside, a high yielding constituent from Anoectochilus roxburghii in streptozotocin diabetic rats. , 2007, Journal of ethnopharmacology.

[4]  Wan-Wan Lin,et al.  Opposite effects of high glucose on MMP‐2 and TIMP‐2 in human endothelial cells , 2007, Journal of cellular biochemistry.

[5]  Wen-Chuan Lin,et al.  The hepatoprotective activity of kinsenoside from Anoectochilus formosanus , 2007, Phytotherapy research : PTR.

[6]  K. Cheng,et al.  Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  Katsuhiko Suzuki,et al.  Synthesis of 3‐O‐β‐D‐Glucopyranosyl‐(3R)‐hydroxybutanolide (Kinsenoside) and 3‐O‐β‐D‐Glucopyranosyl‐(3S)‐hydroxybutanolide (Goodyeroside A) , 2005 .

[8]  Wen-Chuan Lin,et al.  Effect of Anoectochilus formosanus on fibrosis and regeneration of the liver in rats , 2004, Clinical and experimental pharmacology & physiology.

[9]  D. Yue,et al.  High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. , 2003, Atherosclerosis.

[10]  U. Ikeda,et al.  Matrix metalloproteinases and coronary artery diseases , 2003, Clinical cardiology.

[11]  Wen-Chuan Lin,et al.  Antihyperglycaemic And Anti‐Oxidant Properties Of Anoectochilus Formosanus in Diabetic Rats , 2002, Clinical and experimental pharmacology & physiology.

[12]  P. Tsao,et al.  Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. , 2001, Circulation research.

[13]  B. Sassetti,et al.  Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. , 2001, Thrombosis research.

[14]  E. Porteri,et al.  Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus , 2001, Circulation.

[15]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[16]  P. Furness.  Editorial: Basement Membrane Synthesis and Degradation , 1997 .

[17]  P. Libby,et al.  Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a , 1994, Annals of the New York Academy of Sciences.

[18]  R. S. Law,et al.  Anoectochilus formosanus Hay. Contains substances that affect arachidonic acid metabolism , 1990 .

[19]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[20]  K. Brew,et al.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. , 2010, Biochimica et biophysica acta.

[21]  M. Brownlee.  Insight Review Articles , 2022 .